FINWIRES · TerminalLIVE
FINWIRES

Viva Energy Group在澳大利亚证券与投资委员会(ASIC)审查后修改了2025年财务报告的会计准则,股价上涨3%。

By

-- 根据周一发布的声明,Viva Energy Group(ASX:VEA)更改了截至2025年12月31日止年度财务报告中的一项会计判断,导致减值支出增加2500万澳元。此次更改是澳大利亚证券和投资委员会(ASIC)根据其财务报告和审计监督计划进行的审查的结果。 Viva Energy确认其2025年度零售便利店的总减值支出为5.588亿澳元。 监管机构审查了Viva Energy的财务报告,并对其便利店零售店的减值测试方法表示担忧。该方法将部分门店作为一个整体进行评估,理由是壳牌卡是Viva Energy在全澳范围内提供的批发服务,而不是逐个门店进行评估。 ASIC认为这种整体评估方法不恰当,因为Viva Energy完全可以对壳牌卡现金流单元中包含的每个零售门店进行减值评估。 周一,Viva Energy股价上涨3%。

Related Articles

Research

Research Alert: CFRA Drops Stars Coverage Of United Parks And Resorts Inc.

CFRA, an independent research provider, has providedwith the following research alert. Analysts at CFRA have summarized their opinion as follows:We are dropping analytical coverage of PRKS, an amusement park operator, due to a shift in investor focus. Our previous recommendation on shares of PRKS was Hold.

$PRKS
Asia

TVS Srichakra Launches New Eurogrip Tyres Store in Bahraich, India

TVS Srichakra (NSE:TVSSRICHAK, BOM:509243) opened a new exclusive retail store for Eurogrip Tyres, a two-wheeler and three-wheeler tire brand at Bahraich in Uttar Pradesh, India, according to a Monday filing to the Indian stock exchanges.This is the Eurogrip brand's 15th signature store in India.The company's shares were up over 1% in recent trade.

$BOM:509243$NSE:TVSSRICHAK
Asia

Shionogi to Absorb Torii Pharmaceutical in April 2027 Merger

Shionogi & Co (TYO:4507) will absorb its wholly owned subsidiary Torii Pharmaceutical through an absorption-type merger effective April 1, 2027, as it moves to strengthen integration and decision-making, according to a Monday filing on the Tokyo Stock Exchange.The companies signed the merger agreement on April 27 following board approval the same day.Shionogi will remain the surviving entity, while Torii Pharmaceutical will be dissolved, with no new shares or cash consideration issued as part of the transaction.The company said the merger will deepen collaboration and enhance synergies, particularly in therapeutic areas such as allergy and dermatology.

$TYO:4507